The dpa group saw a mixed financial year in 2024: At the group level, dpa reported a moderate decline in turnover, while the parent company Deutsche Presse-Agentur GmbH grew and generated a stable profit. Group turnover fell to 161.5 million euros (2023: 165.9 million euros). This was mainly due to the end of the extensive projects related to the COVID-19 pandemic. By contrast, dpa GmbH increased its turnover to 105.5 million euros (previous year: 104.3 million euros). The net profit remained at
The German Design Council has once again honored outstanding innovations in Berlin. Among the award recipients: DERMALOG Identification Systems GmbH, recognized for its Self Registration Kiosk featuring the integrated all-in-one VF1 scanner – a solution setting new benchmarks for digital security and seamless enrollment processes.
With its Self Registration Kiosk and all-in-one VF1 scanner, DERMALOG has developed a compact solution that integrates every step of a biometric registration p
Reliable measurement results in spite of abrupt level fluctuations / 0.1 mm precision even for level control of molten metals / Special housing allows level measurement in closed containers
The shareholders of Swarovski decide unanimously to create an integrated Crystal Group by incorporating its Wattens-based business, as basis for the next phase of successful business development. All legal disputes have been settled.
With this agreement, the Swarovski, Weis, and Frey families lay the foundation to develop independently their companies, which include Tyrolit and Swarovski Optik in addition to the Crystal Business, and to create for each new unique opportunities for dynamic growt
The winner of the German Non-Fiction Prize 2025 is Ulli Lust, for her work “Die Frau als Mensch. Am Anfang der Geschichte” (“Woman as Human. At the Dawn of History”) (Reprodukt).
Statement from the jury:
“The strong woman as a human being. In her informed and imaginative non-fiction book on the origins of humanity – between evolution and culture – Ulli Lust reveals how the role of women in human history has remained largely invisible. A fundamental r
Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines.
Isomorphic Labs, the AI-first drug discovery company, has announced the appointment of Ben B. Wolf, M.D., Ph.D., as Chief Medical Officer. Dr. Wolf will be based in the company s newly established Cambridge location, where he will establish a group of world-class biomedical talent as the company advances its work translating AI-driven drug discovery
Wiremind, a leading provider of innovative solutions for the transportation and ticketing industry, today announced the launch of its PAXONE OSDM Sandbox, an open environment for testing and validating OSDM-based ticketing and distribution management solutions. This launch positions Wiremind as the fourth major provider to offer an OSDM Sandbox, joining other providers in supporting industry-wide adoption of open, standardized data management.
The Open Sales and Distribution Model (OSDM) is an
BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156, at the GBA1 Meeting 2025 being held June 5-7, 2025, in Montreal, Canada. The GBA1 Meeting 2025 is hosted by McGill University, focusing on all aspects of GBA1 research, from basic science to clinical trials.
BIAL will be presenting the ACTIVATE study, a Phase II trial evaluating the effic
ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for producing Terbium-161 (Tb-161), an emerging medical isotope with significant potential in targeted radiotherapeutics.
This partnership addresses longstanding supply challenges for Gd-160, enabling Isotopia to advance Tb-161-based therapies for prostate cancer, neuroendocrine tumors, and other malignancies.
Isotopia Molecular Imaging, in partnership with Cardirad , proudly announces the launch of Isoprotrace®—an advanced Gallium-68 Gozetotide preparation kit for prostate cancer imaging—in Sweden and Denmark.
The introduction of Isoprotrace® into these Nordic markets marks a significant step forward in expanding access to precision diagnostic tools for prostate cancer. Isoprotrace® is a ready-to-use, multi-dose kit designed for the efficient preparation of Gallium-68 Gozetot
